Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation
25. Oktober 2022 06:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with James G. Krueger, MD, PhD, Co-director,...
Global Apheresis Market to Hit $5.3 Billion by 2031: Allied Market Research
08. Juni 2022 07:45 ET
|
Allied Market Research
Portland, OR, June 08, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Apheresis Market generated $2.4 billion in 2021, and is expected to reach $5.3...
Leukapheresis Market ($133.90Mn by 2028) Growth Forecast at 8.7% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
08. September 2021 10:51 ET
|
The Insight Partners
New York, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Leukapheresis Market: Key InsightsAccording to our new research study on “Leukapheresis Market to 2028 – Global Analysis and Forecast – by Product Type,...